Cargando…

New Era for Usage of Serum Liver Enzymes as A Promising Horizon for the Prediction of Non-Alcoholic Fatty Liver Disease

BACKGROUND: Liver histology remains the gold standard for assessing non-alcoholic fatty liver disease (NAFLD). Noninvasive serological markers and radiological methods have been developed to evaluate steatosis to avoid biopsy. AIM: To put cutoff value for liver enzymes that could predict non-alcohol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salman, Ahmed Abd Allah, Aboelfadl, Soheir Abd Elfattah, Heagzy, Mona Abd Elmenem
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Institute of Immunobiology and Human Genetics 2016
Materias:	Basic Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042614/ https://www.ncbi.nlm.nih.gov/pubmed/27703554 http://dx.doi.org/10.3889/oamjms.2016.092

Ejemplares similares

Leptin and Lipid Profile in Overweight Patient with Type 1 Diabetes
por: Dayem, Soha M. Abd El, et al.
Publicado: (2017)

CD24 Gene Expression as a Risk Factor for Non-Alcoholic Fatty Liver Disease
por: Amin, Mona A., et al.
Publicado: (2023)

Editorial: The Metabolic (Dysfunction)-Associated Fatty Liver Disease (MAFLD) and Non-Alcoholic Fatty Liver Disease (NAFLD) Debate: Why the American Association for the Study of Liver Diseases (AASLD) and European Association for the Study of the Liver (EASL) Consensus Process is Not Representative
por: Fouad, Yasser Mahrous, et al.
Publicado: (2022)

Fractionation of gamma-glutamyltransferase in patients with nonalcoholic fatty liver disease and alcoholic liver disease
por: Sueyoshi, Shigeo, et al.
Publicado: (2016)

Combined Adiponectin Deficiency and Resistance in Obese Patients: Can It Solve Part of the Puzzle in Nonalcoholic Steatohepatitis
por: Salman, Ahmed, et al.
Publicado: (2015)

Serum Resistin Level and Its Receptor Gene Expression in Liver Biopsy as Predictors for the Severity of Nonalcoholic Fatty Liver Disease
por: Hegazy, Mona, et al.
Publicado: (2014)

Angiotensin-Converting Enzyme (ACE) D Allele as a Risk Factor for Increase Serum Interleukin-6 and Interleukin-8 in Psoriasis Patients
por: Elneam, Ahmed I. Abd, et al.
Publicado: (2018)

Partially hydrolyzed guar gum attenuates non-alcoholic fatty liver disease in mice through the gut-liver axis
por: Takayama, Shun, et al.
Publicado: (2021)

Hepatoprotective and antioxidant effects of lycopene on non-alcoholic fatty liver disease in rat
por: Jiang, Wei, et al.
Publicado: (2016)

Three-dimensional perfused human in vitro model of non-alcoholic fatty liver disease
por: Kostrzewski, Tomasz, et al.
Publicado: (2017)

Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease
por: Leung, Christopher, et al.
Publicado: (2016)

Mac-2 binding protein in non-alcoholic fatty liver disease: Is it a reliable diagnostic biomarker? A pilot study
por: El-Aziz, Rokaya Abd, et al.
Publicado: (2020)

Effects of positive acceleration (+Gz stress) on liver enzymes, energy metabolism, and liver histology in rats
por: Shi, Bin, et al.
Publicado: (2019)

Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease
por: Yang, Jia-Min, et al.
Publicado: (2019)

Hepcidin levels correlate to liver iron content, but not steatohepatitis, in non-alcoholic fatty liver disease
por: Marmur, Joel, et al.
Publicado: (2018)

Green tea polyphenols ameliorate non-alcoholic fatty liver disease through upregulating AMPK activation in high fat fed Zucker fatty rats
por: Tan, Yi, et al.
Publicado: (2017)

Targeting HSP47 and HSP70: promising therapeutic approaches in liver fibrosis management
por: Abd El-Fattah, Eslam E., et al.
Publicado: (2022)

Linagliptin alleviates fatty liver disease in diabetic db/db mice
por: Michurina, Svetlana V, et al.
Publicado: (2016)

Nitric Oxide Gene Polymorphism is a Risk Factor for Diabetic Nephropathy and Atherosclerosis in Type 1 Diabetic Patients
por: Dayem, Soha M. Abd El, et al.
Publicado: (2019)

Mismatched effects of receptor interacting protein kinase-3 on hepatic steatosis and inflammation in non-alcoholic fatty liver disease
por: Saeed, Waqar Khalid, et al.
Publicado: (2018)

Prolonged high-fat-diet feeding promotes non-alcoholic fatty liver disease and alters gut microbiota in mice
por: Velázquez, Kandy T, et al.
Publicado: (2019)

Genetic polymorphism in CD14 gene, a co-receptor of TLR4 associated with non-alcoholic fatty liver disease
por: Kapil, Shweta, et al.
Publicado: (2016)

miR-192-5p regulates lipid synthesis in non-alcoholic fatty liver disease through SCD-1
por: Liu, Xiao-Lin, et al.
Publicado: (2017)

Papaya improves non-alcoholic fatty liver disease in obese rats by attenuating oxidative stress, inflammation and lipogenic gene expression
por: Deenin, Wanwisa, et al.
Publicado: (2021)

Hemolysis, elevated liver enzymes and low platelet count (HELLP) syndrome versus severe preeclampsia: a critical care comparative study
por: Zaky, S, et al.
Publicado: (2004)

Freeze-dried Si-Ni-San powder can ameliorate high fat diet-induced non-alcoholic fatty liver disease
por: Zhu, Feng, et al.
Publicado: (2019)

Zinc-α2-glycoprotein 1 attenuates non-alcoholic fatty liver disease by negatively regulating tumour necrosis factor-α
por: Liu, Ting, et al.
Publicado: (2019)

Circulating adipokines in children with nonalcoholic fatty liver disease: possible noninvasive diagnostic markers
por: Mohamed, Amal Ahmed, et al.
Publicado: (2017)

Identification of key pathways and genes in nonalcoholic fatty liver disease using bioinformatics analysis
por: Liu, Jingqi, et al.
Publicado: (2020)

Procyanidin B2 protects against diet-induced obesity and non-alcoholic fatty liver disease via the modulation of the gut microbiota in rabbits
por: Xing, Ya-Wei, et al.
Publicado: (2019)

Mechanism and therapeutic strategy of hepatic TM6SF2-deficient non-alcoholic fatty liver diseases via in vivo and in vitro experiments
por: Li, Zu-Yin, et al.
Publicado: (2022)

F-box only protein 2 exacerbates non-alcoholic fatty liver disease by targeting the hydroxyl CoA dehydrogenase alpha subunit
por: Liu, Zhi, et al.
Publicado: (2023)

Effects of rosuvastatin and/or β-carotene on non-alcoholic fatty liver in rats
por: Seif el-Din, Sayed H., et al.
Publicado: (2015)

LB100 ameliorates nonalcoholic fatty liver disease via the AMPK/Sirt1 pathway
por: Chen, Xue-Yang, et al.
Publicado: (2019)

Significance of MiRNA-34a and MiRNA-192 as a risk factor for nonalcoholic fatty liver disease
por: Ragab, Halla M., et al.
Publicado: (2023)

Diet switch and omega-3 hydroxy-fatty acids display differential hepatoprotective effects in an obesity/nonalcoholic fatty liver disease model in mice
por: Rodriguez-Echevarria, Roberto, et al.
Publicado: (2018)

Angiotensin-converting enzyme 2 improves liver fibrosis in mice by regulating autophagy of hepatic stellate cells
por: Wu, Ying, et al.
Publicado: (2023)

NERVE GROWTH FACTOR, NEUROPEPTIDES AND CUTANEOUS NERVES IN ATOPIC DERMATITIS
por: Hodeib, Abeer, et al.
Publicado: (2010)

Potential Role of New Anthropometric Parameters in Childhood Obesity with or Without Metabolic Syndrome
por: Ismail, Nagwa Abdallah, et al.
Publicado: (2019)

Liver injury in non-alcoholic fatty liver disease is associated with urea cycle enzyme dysregulation
por: Gallego-Durán, Rocío, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ecdesu6o2r4735hsrimbaeibnd